Replicative helicases can translocate through abasic site-induced covalent topoisomerase IV-DNA complexes

Area of Science:

• Molecular Biology
• Biochemistry
• Genetics

Background:

• Topoisomerase inhibitors are crucial in cancer therapy, forming ternary complexes that halt DNA replication and induce breaks.
• DNA lesions can potentially act as endogenous topoisomerase poisons, mimicking drug effects.
• Topoisomerase IV (Topo IV) plays a vital role in DNA decatenation and replication.

Purpose of the Study:

• To investigate the impact of abasic (AP) sites on Topoisomerase IV (Topo IV) activity.
• To determine if AP sites can function as endogenous topoisomerase poisons.
• To elucidate the consequences of AP site-induced Topo IV-DNA complex formation on DNA replication.

Main Methods:

• Enzymatic assays to measure Topo IV activity in the presence of AP sites.
• Analysis of covalent Topo IV-DNA complex formation and reversal.
• Assessment of helicase activities (DnaB and T7 Gene 4) with AP site-induced complexes.

Main Results:

• AP sites stimulate covalent Topo IV-DNA complex formation at specific positions (4 base overhang and -1 position).
• AP sites function as position-specific endogenous Topo IV poisons.
• Reversal of covalent complexes by EDTA/salt is affected by AP site location; -1 position inhibits reversal.
• AP site-induced complexes do not inhibit DnaB and T7 Gene 4 helicase activities.

Conclusions:

• Abasic sites can act as endogenous poisons for Topoisomerase IV.
• The position of the AP site influences the stability and reversal of Topo IV-DNA complexes.
• AP site-induced Topo IV poisoning does not appear to arrest replication fork progression, unlike drug-induced inhibition.